Centessa Pharmaceuticals (CNTA) Receivables - Other (2024 - 2025)
Centessa Pharmaceuticals (CNTA) has disclosed Receivables - Other for 2 consecutive years, with $1.9 million as the latest value for Q3 2025.
- On a quarterly basis, Receivables - Other changed N/A to $1.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.9 million, a N/A change, with the full-year FY2024 number at $287000.0, changed N/A from a year prior.
- Receivables - Other was $1.9 million for Q3 2025 at Centessa Pharmaceuticals, down from $2.2 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $2.2 million in Q2 2025 to a low of $287000.0 in Q4 2024.